Art

J-GLOBAL ID：200902281226242890   Reference number：08A1251251

Monitoring of anti-platelet therapy and anti-platelet drug resistance

抗血小板療法のモニタリングと薬剤抵抗性

Author (2)： TAKANO KATSUHIRO (山梨大 大学院医学工学総合研究部 医学学域 臨床検査医学) ,  OZAKI YUKIO (山梨大 大学院医学工学総合研究部 医学学域 臨床検査医学)
Material： 脳卒中  (日本脳卒中学会機関誌)
Volume： 30  Issue： 6  Page： 953-959  Publication year： Nov. 25, 2008 
JST Material Number： X0160A  ISSN： 0912-0726  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *drug therapy ,...
Semi thesaurus term： antiplatelet effect ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A1251251&from=J-GLOBAL&jstjournalNo=X0160A") }}

JST classification (2)： Clinical application of drugs acting on blood and body fluid  (GW14020X) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (3)： Aspirin ,  Clopidogrel ,  Ticlopidine

Reference (10)：

• GAWAZ, M. Platelets in inflammation and atherogenesis. J Clin Invest. 2005, 115, 3378-3384
• TSCHOEPE, D. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation. 1993, 88, 37-42
• Antithrombotic Trialists' collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J. 2002, 324, 71-96
• MCKEE, SA. Aspirin resistance in cardiovascular disease : a review of prevalence, mechanisms, and clinical significance. Thromb Haemost. 2002, 88, 711-715
• OHMORI, T. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity : involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost. 2006, 4, 1271-1278

Terms in the title (3)： 抗血小板療法 ,  モニタリング ,  薬剤抵抗性